Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Intrauterine Contraceptive Devices (IUD) market 2023-2027: 5-Year (2017-2021) Historic Industry Size & Analysis of 15 Vendors and 7 Countries - Technavio


NEW YORK, Dec. 3, 2022 /PRNewswire/ -- The intrauterine contraceptive devices (IUD) market size is forecast to grow by USD 965.49 million from 2022 to 2027, with an accelerated CAGR of 3.98%, according to the recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region.

Discover some insights on market size before buying the full report. Request a free sample report.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. The Bargaining Power of Buyers & Suppliers and the Threat of New Entrants, Rivalry, and Substitutes have also been analyzed and rated between LOW-HIGH to provide a holistic view of market favorability.

Find Technavio's Exclusive Analysis of Price Sensitivity, Adoption Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria

The intrauterine contraceptive devices (IUD) market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed Below ?

Download a sample report 

Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparative Analysis of Segments, and Y-O-Y Growth of intrauterine contraceptive devices (IUD) market

The market is segmented by type (hormonal intrauterine device and copper intrauterine device) and end-user (hospitals, gynecology clinics, and others).

To procure the data - Buy report!

The increasing number of unplanned pregnancies and unwanted abortions is the key factor driving the global intrauterine contraceptive devices (IUD) market growth.

 The growing number of unplanned pregnancies is expected to contribute to the growth of the global intrauterine contraceptive devices (IUD) market. Unintended pregnancies are one of the most pressing public health problems and a significant issue in global reproductive healthcare, imposing a substantial socioeconomic burden on society and individuals. According to WHO, in developing countries, almost half of the pregnancies among adolescent girls aged 15-19 years are unplanned. The adoption of contraceptive methods can lower the rate of such pregnancies.

Chart & Data Table on Historical Market Size (2017-2021, Historic Industry Size & Analysis of 15 Vendors and 7 Countries

The market is segmented by region (North America, Europe, APAC, and the Rest of World). An analysis of key leading countries has been included.

For Insights on the market dynamics & segmentations, VIEW A PDF SAMPLE !

Related Reports -

Emergency Contraceptive Pills Market by Distribution Channel and Geography ? Forecast and Analysis 2021-2025: The emergency contraceptive pills market size is forecast to grow up to USD 75.56 million at a CAGR of 1.64% during 2020-2025.

Female Contraceptive Market by Distribution Channel, Product, and Geography ? Forecast and Analysis 2023-2027: The female contraceptive market is forecast to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,.22 million

Register for a free trial today and gain instant access to 17,000+ market research
reports. 

Technavio's SUBSCRIPTION platform

Intrauterine Contraceptive Devices (IUD) Market Scope

Report Coverage

Details

Page number

149

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 3.98%

Market growth 2023-2027

USD 965.49 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

3.68

Regional analysis

North America, Europe, APAC, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key countries

US, China, Japan, Germany, and France

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents:

1 Executive Summary         

1.1 Market Overview  

Exhibit 01: Executive Summary ? Chart on Market Overview        

Exhibit 02: Executive Summary ? Data Table on Market Overview    

Exhibit 03: Executive Summary ? Chart on Global Market Characteristics           

Exhibit 04: Executive Summary ? Chart on Market by Geography

Exhibit 05: Executive Summary ? Chart on Market Segmentation by Type          

Exhibit 06: Executive Summary ? Chart on Market Segmentation by End-user    

Exhibit 07: Executive Summary ? Chart on Incremental Growth   

Exhibit 08: Executive Summary ? Data Table on Incremental Growth

Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning     

2 Market Landscape 

2.1 Market ecosystem

Exhibit 10: Parent market      

Exhibit 11: Market Characteristics     

3 Market Sizing

3.1 Market definition

Exhibit 12: Offerings of vendors included in the market definition   

3.2 Market segment analysis 

Exhibit 13: Market segments 

3.3 Market size 2022 

3.4 Market outlook: Forecast for 2022-2027           

Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)    

Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)           

Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)      

Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)           

4 Historic Market Size

4.1 Global intrauterine contraceptive devices (IUD) market 2017 - 2021    

Exhibit 18: Historic Market Size ? Data Table on Global intrauterine contraceptive devices (IUD) market 2017 - 2021 ($ million)

4.2 Type Segment Analysis 2017 - 2021           

Exhibit 19: Historic Market Size ? Type Segment 2017 - 2021 ($ million)       

4.3 End-User Segment Analysis 2017 - 2021   

Exhibit 20: Historic Market Size ? End-User Segment 2017 - 2021 ($ million)       

4.4 Geography Segment Analysis 2017 - 2021   

Exhibit 21: Historic Market Size ? Geography Segment 2017 - 2021 ($ million)       

4.5 Country Segment Analysis 2017 - 2021 

Exhibit 22: Historic Market Size ? Country Segment 2017 - 2021 ($ million)       

5 Five Forces Analysis          

5.1 Five forces summary       

Exhibit 23: Five forces analysis - Comparison between 2022 and 2027        

5.2 Bargaining power of buyers        

Exhibit 24: Chart on Bargaining power of buyers ? Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers     

Exhibit 25: Bargaining power of suppliers ? Impact of key factors in 2022 and 2027        

5.4 Threat of new entrants    

Exhibit 26: Threat of new entrants ? Impact of key factors in 2022 and 2027       

5.5 Threat of substitutes        

Exhibit 27: Threat of substitutes ? Impact of key factors in 2022 and 2027       

5.6 Threat of rivalry    

Exhibit 28: Threat of rivalry ? Impact of key factors in 2022 and 2027       

5.7 Market condition  

Exhibit 29: Chart on Market condition - Five forces 2022 and 2027           

6 Market Segmentation by Type       

6.1 Market segments 

Exhibit 30: Chart on Type - Market share 2022-2027 (%)        

Exhibit 31: Data Table on Type - Market share 2022-2027 (%)           

6.2 Comparison by Type       

Exhibit 32: Chart on Comparison by Type    

Exhibit 33: Data Table on Comparison by Type           

6.3 Hormonal intrauterine device - Market size and forecast 2022-2027    

Exhibit 34: Chart on Hormonal intrauterine device - Market size and forecast 2022-2027 ($ million)

Exhibit 35: Data Table on Hormonal intrauterine device - Market size and forecast 2022-2027 ($ million)

Exhibit 36: Chart on Hormonal intrauterine device - Year-over-year growth 2022-2027 (%)       

Exhibit 37: Data Table on Hormonal intrauterine device - Year-over-year growth 2022-2027 (%)           

6.4 Copper intrauterine device - Market size and forecast 2022-2027    

Exhibit 38: Chart on Copper intrauterine device - Market size and forecast 2022-2027 ($ million)           

Exhibit 39: Data Table on Copper intrauterine device - Market size and forecast 2022-2027 ($ million)

Exhibit 40: Chart on Copper intrauterine device - Year-over-year growth 2022-2027 (%)         

Exhibit 41: Data Table on Copper intrauterine device - Year-over-year growth 2022-2027 (%)           

6.5 Market opportunity by Type

Exhibit 42: Market opportunity by Type ($ million)           

7 Market Segmentation by End-user 

7.1 Market segments 

Exhibit 43: Chart on End-user - Market share 2022-2027 (%)        

Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)           

7.2 Comparison by End-user 

Exhibit 45: Chart on Comparison by End-user           

Exhibit 46: Data Table on Comparison by End-user           

7.3 Hospitals - Market size and forecast 2022-2027   

Exhibit 47: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)           

Exhibit 48: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)    

Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027 (%)           

Exhibit 50: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)   

7.4 Gynecology clinics - Market size and forecast 2022-2027      

Exhibit 51: Chart on Gynecology clinics - Market size and forecast 2022-2027 ($ million)        

Exhibit 52: Data Table on Gynecology clinics - Market size and forecast 2022-2027 ($ million)           

Exhibit 53: Chart on Gynecology clinics - Year-over-year growth 2022-2027 (%)      

Exhibit 54: Data Table on Gynecology clinics - Year-over-year growth 2022-2027 (%)         

7.5 Others - Market size and forecast 2022-2027           

Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)           

Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)           

Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)           

Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)           

7.6 Market opportunity by End-user  

Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape         

8.1 Customer landscape overview    

Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria        

9 Geographic Landscape      

9.1 Geographic segmentation           

Exhibit 61: Chart on Market share by geography 2022-2027 (%)           

Exhibit 62: Data Table on Market share by geography 2022-2027 (%)     

9.2 Geographic comparison  

Exhibit 63: Chart on Geographic comparison           

Exhibit 64: Data Table on Geographic comparison           

9.3 North America - Market size and forecast 2022-2027   

Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)    

Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)        

Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)   

Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)      

9.4 Europe - Market size and forecast 2022-2027           

Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)           

Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)           

Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)           

Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)           

9.5 APAC - Market size and forecast 2022-2027           

Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)           

Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)           

Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)           

Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)           

9.6 Rest of World (ROW) - Market size and forecast 2022-2027    

Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)        

Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)           

Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)      

Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)         

9.7 US - Market size and forecast 2022-2027           

Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million) 

Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)           

Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)           

Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)           

9.8 Germany - Market size and forecast 2022-2027   

Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)           

Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)    

Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)           

Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)   

9.9 China - Market size and forecast 2022-2027

Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)           

Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)           

Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)            105

Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)           

9.10 France - Market size and forecast 2022-2027           

Exhibit 93: Chart on France - Market size and forecast 2022-2027 ($ million)           

Exhibit 94: Data Table on France - Market size and forecast 2022-2027 ($ million)           

Exhibit 95: Chart on France - Year-over-year growth 2022-2027 (%)           

Exhibit 96: Data Table on France - Year-over-year growth 2022-2027 (%)

9.11 Japan - Market size and forecast 2022-2027           

Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)           

Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)           

Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)           

Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)           

9.12 Market opportunity by geography          

Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends  

10.1 Market drivers    

10.2 Market challenges         

10.3 Impact of drivers and challenges          

Exhibit 102: Impact of drivers and challenges in 2022 and 2027           

10.4 Market trends     

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape          

Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption    

Exhibit 104: Overview on factors of disruption           

11.4 Industry risks     

Exhibit 105: Impact of key risks on business

12 Vendor Analysis    

12.1 Vendors covered

Exhibit 106: Vendors covered

12.2 Market positioning of vendors   

Exhibit 107: Matrix on vendor position and classification   

12.3 AbbVie Inc.        

Exhibit 108: AbbVie Inc. - Overview  

Exhibit 109: AbbVie Inc. - Product / Service 

Exhibit 110: AbbVie Inc. - Key offerings        

12.4 Bayer AG           

Exhibit 111: Bayer AG - Overview

Exhibit 112: Bayer AG - Business segments

Exhibit 113: Bayer AG - Key offerings           

Exhibit 114: Bayer AG - Segment focus       

12.5 DKT International           

Exhibit 115: DKT International - Overview    

Exhibit 116: DKT International - Product / Service           

Exhibit 117: DKT International - Key offerings           

12.6 EUROGINE SL  

Exhibit 118: EUROGINE SL - Overview       

Exhibit 119: EUROGINE SL - Product / Service           

Exhibit 120: EUROGINE SL - Key offerings 

12.7 HLL Lifecare Ltd.           

Exhibit 121: HLL Lifecare Ltd. - Overview     

Exhibit 122: HLL Lifecare Ltd. - Product / Service           

Exhibit 123: HLL Lifecare Ltd. - Key offerings           

12.8 Krishco Medical Products Pvt. Ltd.       

Exhibit 124: Krishco Medical Products Pvt. Ltd. - Overview        

Exhibit 125: Krishco Medical Products Pvt. Ltd. - Product / Service       

Exhibit 126: Krishco Medical Products Pvt. Ltd. - Key offerings  

12.9 Laboratoire HRA Pharma SAS  

Exhibit 127: Laboratoire HRA Pharma SAS - Overview        

Exhibit 128: Laboratoire HRA Pharma SAS - Product / Service       

Exhibit 129: Laboratoire HRA Pharma SAS - Key offerings         

12.10 Melbea Innovations Ltd.          

Exhibit 130: Melbea Innovations Ltd. - Overview           

Exhibit 131: Melbea Innovations Ltd. - Product / Service           

Exhibit 132: Melbea Innovations Ltd. - Key offerings         

12.11 Ocon Medical Ltd.       

Exhibit 133: Ocon Medical Ltd. - Overview   

Exhibit 134: Ocon Medical Ltd. - Product / Service           

Exhibit 135: Ocon Medical Ltd. - Key offerings           

12.12 Pregna International Ltd          

Exhibit 136: Pregna International Ltd - Overview           

Exhibit 137: Pregna International Ltd - Product / Service           

Exhibit 138: Pregna International Ltd - Key offerings         

12.13  Prosan International BV         

Exhibit 139: Prosan International BV - Overview           

Exhibit 140: Prosan International BV - Product / Service           

Exhibit 141: Prosan International BV - Key offerings         

12.14 SMB Corp. of India      

Exhibit: SMB Corp. of India - Overview        

Exhibit 142: SMB Corp. of India - Product / Service           

Exhibit 143: SMB Corp. of India - Key offerings           

12.15 TESPRO LLC  

Exhibit 144: TESPRO LLC - Overview          

Exhibit 145: TESPRO LLC - Product / Service           

Exhibit 146: TESPRO LLC - Key offerings    

12.16 The Cooper Companies Inc.   

Exhibit 147 : The Cooper Companies Inc. - Overview        

Exhibit 148: The Cooper Companies Inc. - Business segments   

Exhibit 149: The Cooper Companies Inc. - Key offerings         

Exhibit 150: The Cooper Companies Inc. - Segment focus           

12.17 TRIMEDIC SUPPLY NETWORK Ltd. 

Exhibit 151: TRIMEDIC SUPPLY NETWORK Ltd. - Overview      

Exhibit 152: TRIMEDIC SUPPLY NETWORK Ltd. - Product / Service     

Exhibit 153: TRIMEDIC SUPPLY NETWORK Ltd. - Key offerings

13 Appendix   

13.1 Scope of the report        

13.2 Inclusions and exclusions checklist      

Exhibit 154: Inclusions checklist        

Exhibit 155 : Exclusions checklist     

13.3 Currency conversion rates for US$       

Exhibit 157: Currency conversion rates for US$           

13.4 Research methodology  

Exhibit 158: Research methodology  

Exhibit 159: Validation techniques employed for market sizing  

Exhibit 160: Information sources       

13.5 List of abbreviations       

Exhibit 161: List of abbreviations       

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio


These press releases may also interest you

at 02:05
Animal wound care Market Overview: The global Animal wound care Market is currently valued at USD 1.85billion and is expected to reach USD 1.00 billion by the end of 2029, growing at a CAGR of 7.1% over the next decade. Animal wound care is one of...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to...

at 01:30
Consolidated sales revenue of ?4.876 billion, up 9.8% (+6.6% at CERi), driven by strong growth in international sales Sales revenue for brand-name medicines reached ?3.694 billion, up 12.5% (+8.9% at CERi), and ?1.182 billion for generics, up 2.0%...

at 01:15
BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced the formation of a scientific advisory board consisting of four world-renowned...

at 01:05
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the third quarter of fiscal year 2022 (period ended December 31, 2022). Takeda chief financial officer, Costa Saroukos, commented: "Our third-quarter performance demonstrates...

at 01:00
SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, announces that it has commenced a randomized phase 2 study for the treatment of unresectable pancreatic cancer with SONIRE's next-generation High-Intensity Focused...



News published on 3 december 2022 at 15:00 and distributed by: